RenaissThera
RenaissThera is a biotechnology company focused on creating novel small-molecule therapies for cardio-metabolic diseases, including Diabetes and Obesity.
Problem
Current diabetes and obesity therapies like GLP-1 are limited by being injectable rather than oral, complex and costly to manufacture, expensive and inaccessible to most patients, prone to weight regain once stopped.
Founded
2026
Category
HealthTech
Fund
Fund II
Solution
Developing a portfolio of tablet-based oral small-molecule drugs targeting metabolic pathways such as GLP-1 and GIP, which are already clinically validated by injectable drugs like semaglutide and tirzepatide, while addressing convenience, scalability, and long-term adherence.
FOUNDERS
Ramkesh Meena
Linkedin →
Sudhir Nagarajan
Linkedin →